IDO1 and acute myeloid leukemia: Also, it is conceivable that IDO− AML blasts may start expressing IDO when exposed to an IFN-γ-rich inflammatory milieu, implying that in vivo immune resistance mechanisms centered on IDO could be the result of AML blast cell interactions with IFN-γ-producing cell types, such as T cells or NK cells.